Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials


A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Andalusia : Research Site Updated

COPD Research Study

Anniston : TR31

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : TR20

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : TR7

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : Achieve Clinical Research, LLC an Accel Research Site

Long term safety study of QVA149 in COPD patients with moderate to sever airflow limitation.

Andalusia : SEC Lung LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Andalusia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : Achieve Clinical Research LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Birmingham : UAB Lung Health Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Birmingham : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Birmingham : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : Forest Investigative Site 3675

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : Forest Investigative Site 3836

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : Forest Investigative Site 3056

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : University of Alabama Birmingham Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Florence : Forest Investigative Site 3438

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Foley : Forest Investigative Site 3729

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gulf Shores : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Huntsville : Forest Investigative Site 3911

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jasper : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper : Forest Investigative Site 2423

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mobile : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mobile : Forest Investigative Site 4030

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tuscaloosa : Forest Investigative Site 3769

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arizona

Flagstaff : TR14

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Flagstaff : Research Site Updated

COPD Research Study

Phoenix : Arizona Research Center

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

Phoenix : TR76

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : TR79

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : TR47

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : Research Site Updated

COPD Research Study

Phoenix : Elite Clinical Studies, LLC

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

Tucson : TR46

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Chandler : Forest Investigative Site 3731

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chandler : Forest Investigative Site 3164

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Glendale : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mesa : Forest Investigative Site 4032

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Peoria : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : Forest Investigative Site 4003

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 4038

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 3135

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 3850

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 4024

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 3968

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 3673

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3847

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3917

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3726

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 4046

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 4016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arkansas

Fort Smith : Sparks Regional Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Hot Springs : Forest Investigative Site 4009

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3837

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3810

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

California

Anaheim : Research Site Updated

COPD Research Study

Bell Gardens : TR45

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Fullerton : TR16

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Fullerton : Research Site Updated

COPD Research Study

Lakewood : Research Site Updated

COPD Research Study

Lomita : Research Site Updated

COPD Research Study

Los Angeles : TR59 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Palm Springs : TR57

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Paramount : Center for Clinical Trials, LLC

Attention Smokers and Ex-Smokers Clinical Research Study Participants Needed

Sacramento : Northern California Research

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD

San Diego : TR4

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

San Diego : Encompass Clinical Research

Do you have breathing problems?

San Jose : TR77 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Spring Valley : Encompass Clinical Research

Do you have breathing problems?

Spring Valley : Encompass Clinical Research

Has a long history of smoking left you breathless?

Anaheim : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Bakersfield : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Cerritos : Forest Investigative Site 3750

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Encinitas : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Encinitas : Forest Investigative Site 2402

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Encino : Forest Investigative Site 3876

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fresno : Forest Investigative Site 3849

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fullerton : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Gold River : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Gold River : Forest Investigative Site 3410

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Beach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Huntington Beach : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Huntington beach : Forest Investigative Site 4022

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Park : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Laguna Hills : Forest Investigative Site 3866

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3415

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lomita : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Los Angeles : University of California at Los Angeles Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Los Angeles : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Los Angeles : UCLA

Patients are needed to participate in a clinical research study evaluating Nebulized arformoterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease, COPD, Emphysema or Chronic Bronchitis

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Forest Investigative Site 3757

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Los Angeles : Forest Investigative Site 3471

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Newport Beach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Newport Beach : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Newport Beach : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Newport Beach : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

North Hills : Forest Investigative Site 3417

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Hollywood : Forest Investigative Site 3934

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Northridge : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Palm Springs : Forest Investigative Site 3727

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Palmdale : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Paramount : Forest Investigative Site 3087

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pismo Beach : Forest Investigative Site 3686

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Hueneme : Forest Investigative Site 3861

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Rancho Mirage : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Redlands : Forest Investigative Site 3771

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rialto : Forest Investigative Site 3952

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Riverside : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Riverside : Kaiser Permanente Riverside Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Riverside : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Riverside : Forest Investigative Site 2399

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rolling Hills Estates : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sacramento : Forest Investigative Site 3083

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Forest Investigative Site 3806

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Forest Investigative Site 4039

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : Institute of Healthcare Assessments Inc.

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Diego : University of California San Diego Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

San Diego : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

San Diego : Forest Investigative Site 2345

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : Forest Investigative Site 3707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : 1237.16.01602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

San Jose : Forest Investigative Site 3971

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Ana : Forest Investigative Site 4035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Monica : Forest Investigative Site 3890

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Thousand Oaks : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Harbor UCLA Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Torrance : 1237.16.01601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Upland : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Upland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Vista : Forest Investigative Site 3427

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wildomar : Forest Investigative Site 3977

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado

Boulder : Alpine Clinical Research Center

Study comparing a fixed dose, orally inhaled triple therapy to reduce the rate of moderate and severe exacerbations compared with a fixed dose dual combinations of FF/VI and UMEC/VI in subjects with COPD.

Colorado Springs : TR80

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Aurora : University of Colorado Hospital

Patients are needed to participate in a clinical research study evaluating Plerixafor mobilization of autologous CD117 stem cells for the treatment of COPD, Cystic Fibrosis or Pulmonary Fibrosis

Centennial : Forest Investigative Site 4012

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado Springs : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Colorado Springs : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Colorado Springs : Forest Investigative Site 2707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Denver : National Jewish Health

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Golden : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Golden : Forest Investigative Site 2993

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Connecticut

Waterbury : TR81

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Waterbury : Chase Medical Research, LLC

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 4 Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD). Protocol LAS-MD-45 'ASCENT'

Bristol : Forest Investigative Site 3959

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Danbury : 1012.65.00001 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Hartford : 1237.16.01603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Stamford : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Stamford : Forest Investigative Site 3151

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Waterbury : Forest Investigative Site 3519

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Forest Investigative Site 2461

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware

Newark : Christiana Care Health System

A clinical trial to evaluate treatments for patients with Dyspnea

Wilmington : Forest Investigative Site 3746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Florida

Brandon : Research Site Updated

COPD Research Study

Clearwater : Clinical Research of West Florida, Inc.

Do you have a chronic cough, shortness of breath, or difficulty breathing? Have you been diagnosed with chronic bronchitis, emphysema, or Chronic Obstructive Pulmonary Disease (COPD)?

Clearwater : Clinical Research of West Florida, Inc.

Do you have COPD, Emphysema or Chronic Bronchitis?

Debary : Research Site Updated

COPD Research Study

DeLand : TR18

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Deland : Research Site Updated

COPD Research Study

Doral : TR72

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Edgewater : Research Site Updated

COPD Research Study

Fort Lauderdale : M & O Clinical Research

Diabetes with Asthma or COPD?

Fort Myers : TR50

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Gainesville : TR34

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Hialeah : Research Site Updated

COPD Research Study

Homestead : Research Site Updated

COPD Research Study

Kissimmee : TR29

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kissimmee : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

Miami : Research Site Updated

COPD Research Study

New Port Richey : TR35

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Orlando : Research Site Updated

COPD Research Study

Orlando : Research Site Updated

COPD Research Study

Orlando : Research Site Updated

COPD Research Study

Ormond Beach : TR61

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Palm Harbor : TR42

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease (COPD)

Pensacola : Pensacola Research Consultants Inc.

A Phase 3 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Pensacola : Pensacola Research Consultants Inc.

A Phase 4 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who experience COPD exacerbations.

Pensacola : Research Site Updated

COPD Research Study

Sarasota : TR41

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Sarasota : Research Site Updated

COPD Research Study

Sebring : Research Site Updated

COPD Research Study

St. Petersburg : SCORE Physician Alliance

A COPD Study is being conducted to reveal the impact of SYMBICORT in reducing exacerbations in COPD.

Tamarac : TR21

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD ?

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD? We are seeking participants who are currently taking Advair or Symbicort on a daily basis to evaluate an investigational medication for COPD

Tampa : Clinical Research of West Florida, Inc.

Are you a current or former smoker?

Tampa : TR53

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Research Site Updated

COPD Research Study

Tampa : University of South Florida - Asthma, Allergy & Immunology Clincal Research Unit

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD)

Winter Park : TR83

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Bay Pines : Forest Investigative Site 2339

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Boynton Beach : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brandon : Tampa Bay Clinical Research Center

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Brandon : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brandon : Forest Investigative Site 2722

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 3487

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 3733

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clearwater : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : Clinical Research of West Florida

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Clearwater : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : Forest Investigative Site 2721

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Davie : Melvin Propis M.D.

A clinical trial to evaluate treatments using Adipose Derived Stem Cell (ADSC) Therapy for patients with Chronic Obstructive Pulmonary Disease (COPD)

Daytona Beach : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Daytona Beach : Forest Investigative Site 3945

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Debary : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Debary : Forest Investigative Site 3500

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Defuniak Springs : Forest Investigative Site 4053

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

DeLand : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Deland : Forest Investigative Site 3990

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delray Beach : Forest Investigative Site 3859

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Edgewater : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Eustis : Forest Investigative Site 4059

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fort Lauderdale : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fort Lauderdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Hialeah : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3947

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3897

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3992

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3863

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3068

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hollywood : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hollywood : Forest Investigative Site 2960

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Homestead : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Jacksonville : Mayo Clinic Jacksonville Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Jacksonville : University of Florida, Jacksonville

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension or Chronic Obstructive Pulmonary Disease

Jacksonville : Forest Investigative Site 3818

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jupiter : Forest Investigative Site 3804

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Pulmonary Disease Specialist/PDS Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Kissimmee : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Kissimmee : Forest Investigative Site 3000

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3833

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3783

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 475

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Leesburg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Maitland : Forest Investigative Site 3664

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Melbourne : Forest Investigative Site 3955

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Armando Pineda Velez

A clinical trial to evaluate treatments using Adipose Derived Stem Cells for patients with Chronic Obstructive Pulmonary Disease

Miami : Well Pharma Medical Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Miami : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Miami : Ageless Institute

Patients are needed to participate in a clinical research study evaluating Adipose-Derived Stem Cell (ADSC) Therapy for the treatment of Chronic Obstructive Pulmonary Disease

Miami : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Miami : Forest Investigative Site 4023

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3918

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3844

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3948

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3949

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3795

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3928

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3978

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3790

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3950

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3942

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3938

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3921

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami Beach : Forest Investigative Site 3872

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami Springs : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Miramar : Forest Investigative Site 3758

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Naples : Forest Investigative Site 3362

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Smyrna Beach : Forest Investigative Site 3860

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : Forest Investigative Site 4033

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : Forest Investigative Site 3794

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Orlando : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Orlando : Florida Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Orlando : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Orlando : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Orlando : Forest Investigative Site 3111

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ormond Beach : Forest Investigative Site 2714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oviedo : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Oviedo : Forest Investigative Site 3693

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Panama City : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Panama City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Pembroke Pines : Forest Investigative Site 3925

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pensacola : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Pensacola : Forest Investigative Site 2536

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Charlotte : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Port Orange : Forest Investigative Site 2954

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sarasota : Sarasota Memorial Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Sarasota : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sarasota : Forest Investigative Site 3360

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sebring : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Sebring : Forest Investigative Site 4042

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Seminole : Forest Investigative Site 3858

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Miami : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

St. Petersburg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

St. Petersburg : Forest Investigative Site 3645

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3426

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 4028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3807

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tamarac : Forest Investigative Site 2417

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tampa : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : Clinical Research of West Florida, Inc.

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Clinical Research of West Florida

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Tampa General Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Tampa : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Forest Investigative Site 2386

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Vero Beach : Forest Investigative Site 3820

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wellington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Florida Premier Research Institute

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Winter Park : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Forest Investigative Site 2751

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winter Park : Forest Investigative Site 3988

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Georgia

Atlanta : NeuroTrials Research

Breathe New Life into COPD Research!

Blue Ridge : River Birch Research Alliance, LLC

COPD (Chronic Obstructive Pulmonary Disease)

Calhoun : Research Site Updated

COPD Research Study

Columbus : Columbus Regional Research Institute

Chronic Obstructive Pulmonary Disease which includes chronic bronchitis and emphysema

Columbus : Columbus Regional Research Institute

Do you have COPD, Emphysema or Chronic Bronchitis?

Columbus : Columbus Regional Research Institute

Do you or a loved one live with COPD, also known as emphysema or chronic bronchitis? If so, you may be interested in a local clinical research opportunity.

Duluth : TR15

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lawrenceville : TR25

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Savannah : Southeast Regional Research Group (SRRG)

Do you have COPD* (Chronic Obstructive Pulmonary Disease)

Savannah : Southeast Regional Research Group - Savannah

Do you or a loved one live with COPD, also known as emphysema or chronic bronchitis? If so, you may be interested in a local clinical research opportunity.

Woodstock : Research Site Updated

COPD Research Study

Atlanta : Piedmont Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Atlanta : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Atlanta : Forest Investigative Site 2542

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Blue Ridge : Forest Investigative Site 2746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Calhoun : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Duluth : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Duluth : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Gainesville : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lawrenceville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Lawrenceville : Forest Investigative Site 2730

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Marietta : Forest Investigative Site 3669

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norcross : Forest Investigative Site 3868

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norcross : Forest Investigative Site 4068

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rincon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Savannah : Forest Investigative Site 3989

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3832

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3672

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Stockbridge : Forest Investigative Site 4045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Woodstock : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Woodstock : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Woodstock : Forest Investigative Site 2424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho

Eagle : Research Site Updated

COPD Research Study

Coeur d'Alene : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : H.C. Research LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Coeur d'Alene : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Eagle : Forest Investigative Site 3400

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3812

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3979

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Meridian : Forest Investigative Site 3755

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Illinois

Normal : TR27

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

O'Fallon : Research Site Updated

COPD Research Study

Skokie : TR40

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Burr Ridge : Forest Investigative Site 3725

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chicago : Northwestern Memorial Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Chicago : University of Chicago Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Chicago : University of Chicago Medical Center

A clinical trial to evaluate treatments using Placebo and Nebivolol for patients with High Blood Pressure

Evergreen Park : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Gillespie : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Gillespie : Forest Investigative Site 3784

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morton : Forest Investigative Site 3680

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Normal : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Normal : Forest Investigative Site 3651

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Chicago : Forest Investigative Site 4048

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

O'Fallon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

O'Fallon : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

O'Fallon : Forest Investigative Site 2967

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Peoria : Forest Investigative Site 3908

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Indiana

Anderson : Community Clinical Research Center

A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo and Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open-Label) as an Active Control

Elwood : Forest Investigative Site 3803

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Michigan City : Forest Investigative Site 3789

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : Forest Investigative Site 3656

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : Forest Investigative Site 3756

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Valparaiso : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Valparaiso : Forest Investigative Site 3966

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Iowa

Council Bluffs : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Iowa City : Forest Investigative Site 3683

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Iowa City : University of Iowa

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Kansas

Kansas City : Forest Investigative Site 3702

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lenexa : Forest Investigative Site 3855

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Topeka : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Topeka : Forest Investigative Site 2634

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kentucky

Lexington : Kentucky Medical Research

COPD Moderate to Severe

Lexington : University of Kentucky Chandler Medical Center

Research Participants Needed - The COPD Health Screening Study

Bowling Green : Forest Investigative Site 2372

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hazard : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Lexington : University of Kentucky

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lexington : Forest Investigative Site 3856

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisville : University of Louisville, Pulmonary Division

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Louisville : Forest Investigative Site 3045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisville : Forest Investigative Site 4005

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Madisonville : Forest Investigative Site 3933

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisiana

Sunset : Research Site Updated

COPD Research Study

Zachary : TR51

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Covington : Forest Investigative Site 3881

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Eunice : Forest Investigative Site 3793

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lafayette : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Metairie : Forest Investigative Site 3880

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Orleans : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

New Orleans : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

New Orleans : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

New Orleans : New Orleans Center for Clinical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

New Orleans : Forest Investigative Site 3878

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Opelousas : Forest Investigative Site 3355

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shreveport : Louisiana State University Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Shreveport : Forest Investigative Site 3961

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shreveport : Forest Investigative Site 4054

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Slidell : Forest Investigative Site 3661

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sunset : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Sunset : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Zachary : Forest Investigative Site 3800

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maine

Bangor : Forest Investigative Site 3357

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Biddeford : Forest Investigative Site 3886

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maryland

Baltimore : University of Maryland Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Baltimore : Forest Investigative Site 3025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Baltimore : Forest Investigative Site 2505

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Columbia : Howard County Center for Lung and Sleep Medicine, LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Elkridge : Forest Investigative Site 3689

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Towson : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Towson : Forest Investigative Site 3670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Towson : Forest Investigative Site 3883

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

White Marsh : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Massachusetts

Fall River : TR33

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Boston : Beth Israel Deaconess Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Boston : Brigham and Women's Hospital

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Burlington : Lahey Clinic Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Fall River : Forest Investigative Site 3124

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dartmouth : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

North Dartmouth : Forest Investigative Site 2549

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pittsfield : Forest Investigative Site 3994

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Worcester : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Worcester : Reliant Medical Group

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Michigan

Ann Arbor : ClinSite, LLC

Diagnosed with COPD, Chronic Bronchitis or Emphysema?

Bingham Farms : QUEST Research Institute

Chronic Obstructive Pulmonary Disease Study

Kalamazoo : TR78

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kalamazoo : Research Site Updated

COPD Research Study

Livonia : Research Site Updated

COPD Research Study

Rochester : Research Site Updated

COPD Research Study

Troy : Research Site Updated

COPD Research Study

Ann Arbor : University of Michigan Health System

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bingham Farms : Forest Investigative Site 4018

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Buckley : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Buckley : Forest Investigative Site 4013

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kalamazoo : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Livonia : Pulmonary Research Institute of Southeast Michigan

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Livonia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Livonia : Forest Investigative Site 2498

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rochester : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Stevensville : Forest Investigative Site 3035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Troy : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Minnesota

Edina : Research Site Updated

COPD Research Study

Fridley : Research Site Updated

COPD Research Study

Minneapolis : TR2

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : Clinical Research Institute, MN

COPD Research Study for Smokers or Ex-Smokers

Plymouth : TR1

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : Research Site Updated

COPD Research Study

Edina : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Edina : Minnesota Lung Center

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Edina : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edina : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fridley : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Fridley : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Minneapolis : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : Minnesota Lung Center

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : University of Minnesota Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Minneapolis : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Minneapolis : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : Forest Investigative Site 2381

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Plymouth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Rochester : Forest Investigative Site 2409

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Woodbury : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Woodbury : Minnesota Lung Center

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Mississippi

Missouri

Belton : Research Site Updated

COPD Research Study

St. Charles : Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

St. Charles : Midwest Chest Consultants, PC

A Phase III, 52-week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease.

St. Charles : Midwest Chest Consultants, PC

GOLDEN-5 - A nebulized study medication for Obstructive Lung Disease

St. Charles : Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

St. Louis : Midwest Clinical Research LLC

Are you a current or former smoker? Do you have a diagnosis of Chronic Obstructive Pulmonary Disease or COPD?

St. Louis : The Clinical Research Center, LLC

Are you Currently Experiencing Symptoms with Your COPD?

St. Louis : TR23

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : The Clinical Research Center, LLC

Have you experienced a flare-up in your COPD symptoms over the past year?

Chesterfield : Forest Investigative Site 2361

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : Forest Investigative Site 3954

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kansas City : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Kansas City : Forest Investigative Site 3154

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Saint Charles : Midwest Chest Consultants PC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Springfield : Forest Investigative Site 3411

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Charles : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St. Charles : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

St. Charles : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St. Charles : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St. Charles : Forest Investigative Site 2413

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St. Louis : The Clinical Research Center

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : Midwest Clinical Research LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : Washington University in St. Louis

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

St. Louis : Forest Investigative Site 3696

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3799

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 2956

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montana

Billings : TR11 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Missoula : Research Site Updated

COPD Research Study

Missoula : Montana Medical Research, Inc.

Do You Have COPD, Emphysema or Chronic Bronchitis?

Belton : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Missoula : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Missoula : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Missoula : Forest Investigative Site 2957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nebraska

Fremont : Research Site Updated

COPD Research Study

Bellevue : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Bellevue : Forest Investigative Site 2972

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fremont : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fremont : Forest Investigative Site 3873

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Grand Island : Forest Investigative Site 3910

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lincoln : Forest Investigative Site 3167

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3896

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : UNMC College of Medicine

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Omaha : University of Nebraska Medical Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 2982

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3653

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 4002

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3451

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : University of Nebraska Medical Center

Patients are needed to participate in a clinical research study to evaluate COPD

Papillion : Forest Investigative Site 3877

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Papillion : Forest Investigative Site 4037

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Papillion : Forest Investigative Site 3997

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nevada

Las Vegas : TR65

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Las Vegas : Research Site Updated

COPD Research Study

Las Vegas : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Las Vegas : Forest Investigative Site 2973

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3874

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3779

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Reno : Forest Investigative Site 3770

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Jersey

Jersey City : CarePoint Health Research Institute

Having difficulty breathing? Have you been diagnosed with COPD?

Linden : Biomedical Research Alliance of New York

Chronic Obstructive Pulmonary Disease (COPD) and a history of or at risk for cardiovascular disease - Adults

Belvidere : Forest Investigative Site 3915

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Camden : Cooper University Hospital Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

East Brunswick : Forest Investigative Site 3835

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Elizabeth : Forest Investigative Site 3932

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Haddon Heights : Forest Investigative Site 3674

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Marlton : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Ocean : Forest Investigative Site 2944

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summit : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Summit : Forest Investigative Site 2418

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toms River : Forest Investigative Site 3743

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Warren : Forest Investigative Site 3902

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Mexico

Albuquerque : Forest Investigative Site 2393

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York

Bronx : Research Site Updated

COPD Research Study

Bronxville : TR36 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Brooklyn : Research Site Updated

COPD Research Study

Buffalo : TR71 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Elmira : Health Sciences Research Center

Attention Smokers and Ex-smokers. Do you have trouble breathing or a persistent cough?

Endwell : Regional Clinical Research, Inc.

A national study for people with shortness of breath and other respiratory problems.

Endwell : Regional Clinical Research, Inc.

Do you have any of these problems? Shortness of Breath? Cough? Chronic Bronchitis? Emphysema? Wheezing? Phlegm? Chronic Obstructive Pulmonary Disease?

New Hyde Park : Parker Jewish Institute

People with Chronic Obstructive Pulmonary Disease are asked to participate in a research study being conducted at Parker Jewish Institute for Health Care and Rehabilitation

Rochester : TR62 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Rochester : AAIR Research Center

Symbicort or Formoterol COPD Study

Bronx : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Bronx : Lincoln Medical and Mental Health Center

A clinical trial to evaluate treatments for patients with Dyspnea

Bronx : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Brooklyn : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brooklyn : Forest Investigative Site 2532

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Hills : Forest Investigative Site 3843

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Hyde Park : Forest Investigative Site 3851

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Windsor : Forest Investigative Site 3110

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York : Columbia University Medical center / New York Presbyterian Hospital

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Dyspnea

New York : Forest Investigative Site 3741

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Syracuse : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Syracuse : Forest Investigative Site 3118

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wappingers Falls : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Westfield : Forest Investigative Site 3671

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Carolina

Boone : TR66

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Calabash : Research Site Updated

COPD Research Study

Charlotte : Research Site Updated

COPD Research Study

Hendersonville : TR24

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Hickory : Research Site Updated

COPD Research Study

Huntersville : TR17 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Raleigh : PMG Research of Raleigh

Do you have Swimmer's Ear?

Salisbury : TR43

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Shelby : Research Site Updated

COPD Research Study

Wilmington : PMG Research of Wilmington

Chronic Obstructive Pulmonary Disease (COPD) – History of Flare-Ups (Exacerbations)

Wilmington : PMG Research of Wilmington

COPD Study – Past or Current Cigarette Smokers

Wilmington : PMG Research of Wilmington

If you have Chronic Obstructive Pulmonary Disease (COPD), you need to know about Alpha-1 Antitrypsin Deficiency.

Winston-Salem : TR30 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Asheville : Forest Investigative Site 3845

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Asheville : Forest Investigative Site 3658

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Burlington : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Calabash : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chapel Hill : UNC-Chapel Hill

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Charlotte : Carolinas Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Charlotte : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Charlotte : Forest Investigative Site 3091

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3785

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3909

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3768

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Durham : Duke University Medical Center

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Elizabeth City : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Elizabeth City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Gastonia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : Forest Investigative Site 3983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3923

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hendersonville : Forest Investigative Site 4064

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hickory : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

High Point : Forest Investigative Site 3903

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntersville : Clinical Research of Lake Norman

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Huntersville : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Huntersville : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Lenoir : Forest Investigative Site 3736

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lexington : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mooresville : Forest Investigative Site 3688

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Salisbury : Forest Investigative Site 3889

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shelby : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Shelby : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Shelby : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Shelby : Forest Investigative Site 3142

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Statesville : Forest Investigative Site 2953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wilmington : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Wilmington : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Wilmington : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Wilmington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Wilmington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Wilmington : Forest Investigative Site 3109

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Winston-Salem : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winston-Salem : Wake Forest University Baptist Medical Center

Patients are needed to participate in a clinical research study evaluating NIOX MINO® for the treatment of Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3786

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 4019

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3796

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dakota

Fargo : Lillestol Research, LLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Fargo : Forest Investigative Site 3687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ohio

Canton : Research Site Updated

COPD Research Study

Columbus : TR68

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Columbus : TR54 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Research Site Updated

COPD Research Study

Dayton : TR85

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kettering : TR37

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Marion : Research Site Updated

COPD Research Study

Toledo : Research Site Updated

COPD Research Study

Willoughby : TR32

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Canton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Canton : Forest Investigative Site 2704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : IVA Researcb

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

Cincinnati : University of Cincinnati Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Cincinnati : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Cincinnati : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Forest Investigative Site 2343

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : Forest Investigative Site 3780

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cleveland : Metrohealth Medical Center

A clinical trial to evaluate treatments for patients with Dyspnea

Cleveland : The Cleveland Clinic

Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing

Columbus : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : Remington Davis Inc

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Columbus : Forest Investigative Site 2980

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dayton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Dayton : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Dayton : Forest Investigative Site 3655

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware : Forest Investigative Site 3708

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dublin : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dublin : Forest Investigative Site 3665

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kettering : Forest Investigative Site 4056

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Marion : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Maumee : Forest Investigative Site 3710

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sylvania : Forest Investigative Site 2425

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Toledo : Forest Investigative Site 3646

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : Forest Investigative Site 3713

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Youngstown : Forest Investigative Site 3893

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma

Oklahoma City : TR55

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Edmond : Forest Investigative Site 4060

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norman : Forest Investigative Site 3691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Oklahoma City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Oklahoma City : Forest Investigative Site 3654

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3695

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3892

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 2745

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3699

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : Forest Investigative Site 4025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : Forest Investigative Site 4027

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Yukon : Forest Investigative Site 3767

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oregon

Eugene : TR52

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Medford : Research Site Updated

COPD Research Study

Medford : Sunstone Medical Research, LLC

Persons struggling with symptoms of COPD are needed to help evaluate an investigational COPD medication.

Medford : Sunstone Medical Research, LLC

Seeking past or current smokers with severe COPD (Chronic Obstructive Pulmonary Disease) also known as emphysema or chronic bronchitis, to participant in a Clinical Research Study.

Clackamas : Kaiser Permanente Northwest Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Medford : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Medford : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Medford : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Medford : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Medford : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Medford : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Medford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Portland : Forest Investigative Site 3766

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pennsylvania

Bethlehem Township : TR38

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lansdale : TR75

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : TR71

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : TR74

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Uniontown : TR67 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Uniontown : Research Site Updated

COPD Research Study

Abington : Forest Investigative Site 3723

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Altoona : Forest Investigative Site 3935

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Beaver : Forest Investigative Site 3650

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Carnegie : Forest Investigative Site 3681

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Downingtown : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Downingtown : Forest Investigative Site 3363

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Erie : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : Forest Investigative Site 2352

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Harleysville : Forest Investigative Site 3692

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Harleysville : Forest Investigative Site 3957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hershey : Penn State Milton S. Hershey Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Jefferson Hills : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Langhorne : Forest Investigative Site 3745

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Monroeville : Forest Investigative Site 3685

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Penndel : Forest Investigative Site 3690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3801

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3774

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Philadelphia : University of Pennsylvania Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Philadelphia : Pennsylvania Hospital

A clinical trial to evaluate treatments for patients with Dyspnea

Philadelphia : Temple University Hospital

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Philadelphia : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Philadelphia : Temple University Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Phoenixville : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : Forest Investigative Site 2715

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Smithfield : Forest Investigative Site 3704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tipton : Forest Investigative Site 3016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3119

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wyomissing : Forest Investigative Site 3941

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rhode Island

East Greenwich : TR63 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Johnston : Clinical Partners, LLC

Chronic Bronchitis or Emphysema-also known as Chronic Obstructive Pulmonary Disease which is most often caused by cigarette smoking.

East Providence : Forest Investigative Site 2678

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Carolina

Anderson : TR56

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Anderson : TR22

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Easley : TR13

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Easley : Research Site Updated

COPD Research Study

Fort Mill : Piedmont Research Partners, LLC

Double-blind, randomized, placebo-controlled, parallel-group, phase IV study to evaluate the effect of Aclidinium Bromide on long-term cardiovascular safety and COPD exacerbations in patients with moderate to severe COPD

Gaffney : TR8

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Greenville : TR69

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Hodges : Research Site Updated

COPD Research Study

Mt. Pleasant : TR19

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : TR6 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : Research Site Updated

COPD Research Study

Spartanburg : TR9

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Spartanburg Medical Research

Double-Blind study evaluating the effect of Fluticasone Furoate/Vilanterol Inhalation powder once daily comparted with Vilanterol Inhalation powder once daily on Bone Mineral Density in subjects with COPD.

Spartanburg : Spartanburg Medical Research

Inhaled Nitric Oxide/Inopulse® Ds-C Combination Product

Union : TR3

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Williamston : TR84

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Anderson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Anderson : Forest Investigative Site 3817

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Lowcountry Lung and Critical Care, PA

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Charleston : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Charleston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Forest Investigative Site 3647

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 2407

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 3344

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Columbia : Forest Investigative Site 3697

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Easley : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Easley : Easley Clinical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Easley : Palmetto Medical Research Associates

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Easley : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Easley : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Easley : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Easley : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Easley : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Easley : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Fort Mill : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Fort Mill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : Forest Investigative Site 3456

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Gaffney : Gaffney Pharmaceutical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Gaffney : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : Forest Investigative Site 3742

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : Forest Investigative Site 3455

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Greenville : Greenville Pharmaceutical Research, Inc.

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Upstate Pharmaceutical Research, Inc.

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Chandar Abboy

A clinical research study of Peforomist-Placebo and Perforomist, nebulization, COPD for the treatment of COPD

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Greenville : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Forest Investigative Site 3700

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hodges : Forest Investigative Site 3924

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longs : Forest Investigative Site 3778

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mt. Pleasant : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mt. Pleasant : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Mt. Pleasant : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pelzer : Forest Investigative Site 2670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rock Hill : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Rock Hill : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Rock Hill : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Rock Hill : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Seneca : Hope Clinical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Seneca : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : S. Carolina Pharmaceutical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : Forest Investigative Site 2691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summerville : Forest Investigative Site 3677

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Union : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Union : CU Pharmaceutical Research

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Union : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Union : Forest Investigative Site 3017

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Dakota

Rapid City : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Rapid City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rapid City : Forest Investigative Site 2892

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tennessee

Brentwood : TR60

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Bristol : TR73

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Knoxville : TR5

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

New Tazewell : TR26 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Athens : Forest Investigative Site 3841

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chattanooga : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Chattanooga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Chattanooga : Forest Investigative Site 3857

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fayetteville : Forest Investigative Site 3075

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Johnson City : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Knoxville : New Phase Clinical Research & Development

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Knoxville : University of Tennessee Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Knoxville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Shelbyville : Forest Investigative Site 3864

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Spring Hill : Forest Investigative Site 3919

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Texas

Arlington : Research Site Updated

COPD Research Study

Boerne : Research Site Updated

COPD Research Study

Corsicana : Research Site Updated

COPD Research Study

Dallas : TR58

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Edinburg : Research Site Updated

COPD Research Study

El Paso : TR39 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Houston : Research Site Updated

COPD Research Study

Houston : Research Site Updated

COPD Research Study

Houston : Research Site Updated

COPD Research Study

Houston : Research Site New

COPD Research Study

Houston : Research Site Updated

COPD Research Study

Houston : Research Site New

COPD Research Study

Houston : Research Site Updated

COPD Research Study

Houston : Research Site Updated

COPD Research Study

Houston : DM Clinical Research

Type 2 Diabetes- Houston,TX

Katy : Research Site Updated

COPD Research Study

Kingwood : TR12 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lewisville : TR49 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Longview : TR64

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Longview : Research Site Updated

COPD Research Study

McKinney : Research Site Updated

COPD Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : TR10 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

San Antonio : Sun Research Institute

Do you smoke cigarettes? Do you suffer from COPD? You may qualify to participate in a study.

San Antonio : Diagnostics Research Group

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Allergy Diagnostics

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Lung Diagnostics, LTD

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Women's Diagnostics

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

Tomball : DM Clinical Research

COPD (Chronic Obstructive Pulmonary Disease)

Amarillo : Forest Investigative Site 3777

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arlington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Arlington : Forest Investigative Site 3737

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Austin : Forest Investigative Site 0564

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Boerne : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Carrollton : Forest Investigative Site 3738

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Corsicana : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Corsicana : Forest Investigative Site 3359

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : UT Southwestern Medical Center at Dallas Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Dallas : Forest Investigative Site 3435

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : Forest Investigative Site 3798

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dickinson : Forest Investigative Site 3854

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Duncanville : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Edinburg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Fort Worth : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fort Worth : 1012.65.00002 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Worth : Forest Investigative Site 2348

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Georgetown : Forest Investigative Site 3870

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Houston : Michael DeBakey VA Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Houston : Texas Institute of Chest and Sleep Disorders, PA

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Houston : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Houston : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Houston : Forest Investigative Site 3871

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3929

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3991

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3937

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Katy : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Katy : Forest Investigative Site 3927

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Killeen : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Kingwood : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Longview : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Lubbock : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

McKinney : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

North Richland Hills : Forest Investigative Site 3882

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Antonio : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : Diagnostics Research Group

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : Forest Investigative Site 3894

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sealy : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3879

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3792

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tyler : Forest Investigative Site 2703

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waco : Forest Investigative Site 3875

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Webster : Forest Investigative Site 3916

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Utah

Bountiful : Research Site Updated

COPD Research Study

Midvale : Research Site Updated

COPD Research Study

Salt Lake City : Optimum Clinical Research, Inc.

A one-year study looking to evaluate the efficacy and safety of benralizumab (MEDI-365) in patients with severe to very severe COPD.

Salt Lake City : Optimum Clinical Research, Inc.

COPD/Emphysema/Chronic Bronchitis

Bountiful : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Midvale : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Ogden : Forest Investigative Site 3748

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ogden : Forest Investigative Site 4014

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Salt Lake City : University of Utah Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Salt Lake City : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Salt Lake City : Forest Investigative Site 3712

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Vermont

Burlington : Fletcher Allen Medical Center Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Virginia

Arlington : Millennium Clinical Trials, L.L.C.

Do you have Chronic Obstructive Pulmonary Disease also known as COPD?

Newport News : Health Research of Hampton Roads, Inc.

Emphysema/COPD/ Chronic Smoker’s Bronchitis Research

Norfolk : TR82 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Virginia Research Center

Adults With COPD - Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Richmond : Pulmonary Associates of Richmond, Inc.

Are you being treated for Chronic Obstructive Pulmonary Disease?

Richmond : TR44

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Research Site Updated

COPD Research Study

Richmond : Research Site Updated

COPD Research Study

Richmond : Research Site Updated

COPD Research Study

Abingdon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Abingdon : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Abingdon : Forest Investigative Site 3047

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlottesville : University of Virginia

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

Danville : Forest Investigative Site 3981

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Manassas : Forest Investigative Site 3705

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Midlothian : Forest Investigative Site 3776

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norfolk : Forest Investigative Site 3852

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : Virginia Commonwealth University Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Richmond : Virginia Commonwealth University

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease(COPD)

Richmond : Pulmonary Associates of Richmond

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Richmond : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Forest Investigative Site 2460

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Forest Investigative Site 3775

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Forest Investigative Site 4043

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Washington

Renton : Rainier Clinical Research Center, Inc.

COPD - Chronic Obstructive Pulmonary Disease - Study. Do You Have COPD?

Tacoma : Pulmonary Consultants, P.L.L.C.

Are you at least 40 years old and have COPD? Did you have worsening of symptoms that required the use of antibiotics, prednisone or hospitalization in the last year?

Tacoma : TR28 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tacoma : Pulmonary Consultants, P.L.L.C.

Do you suffer from Diabetes...With Asthma or COPD?

Bellevue : Forest Investigative Site 4061

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Bellingham : Forest Investigative Site 2690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Orchard : Forest Investigative Site 3711

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Renton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Seattle : University of Washington Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Spokane : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane : Forest Investigative Site 3422

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Spokane Valley : Forest Investigative Site 3127

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tacoma : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tacoma : Pulmonary Consultants PLLC

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tacoma : Forest Investigative Site 2687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

West Virginia

Charleston : Forest Investigative Site 3840

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lewisburg : Forest Investigative Site 3823

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morgantown : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Morgantown : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Morgantown : Forest Investigative Site 3682

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wisconsin

Middleton : Forest Investigative Site 3660

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Milwaukee : Medical College of Wisconsin Updated

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Verona : Forest Investigative Site 2983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Verona : Forest Investigative Site 3951

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Argentina

Berazategui : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Buenos Aires : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Ciudad de Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Concepción del Uruguay : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

La Plata : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Lanus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rosario : Novartis Investigative Site

A clinical research study of Indacaterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Salta : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucuman : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucuman : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucumán : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Santa Fe : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Australia

Adelaide : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Carina Heights : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Clayton : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Daw Park : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Daw Park : 1237.16.61601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Frankston : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Gosford : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Liverpool : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Murdoch : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Murdoch : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Nedlands : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Nedlands : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Toorak Gardens : 1237.16.61602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Wentworthville : Department of Respiratory & Sleep Medicine, Westmead Hospital

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Austria

Amstetten : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Feldbach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Feldbach : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Feldkirch : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Feldkirch : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Grieskirchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Innsbruck : Christian Kähler

Patients are needed to participate in a clinical research study evaluating Nasal oxygen insufflation with a TNI® 20 oxy device and Nasal insufflation of oxygen for the treatment of COPD or Hypercapnia

Kirchdorf an der Krems : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Leoben : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Linz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Linz : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Salzburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Salzburg : 1237.16.43602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Thalheim bei Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vienna : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vienna : Otto-Wagner-Spital Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Wien : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Wien : 1237.16.43601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Belgium

Aalst : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussels : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Brussels : CHU Saint Pierre Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edegem : University Hospital Antwerp

A clinical research study of intrapulmonary percussive ventilation and standard treatment for the treatment of Chronic Obstructive Pulmonary Disease

Edegem : Antwerp University Hospital

Patients are needed to participate in a clinical research study of Functional Respiratory Imaging to evaluate Pulmonary Disease, Chronic Obstructive

Eghezée : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Faulx-les-Tombes : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Genk : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Genk : 1237.16.32603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gent : Universiteit Gent Updated

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Gilly : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Gilly : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gilly : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gosselies : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hasselt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hasselt : 1237.16.32602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Ieper : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Jambes : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Jambes : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Jambes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jambes : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Leuven : UZ Gasthuisberg

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Leuven : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Leuven : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Leuven : University Hospital Leuven Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Leuven : 1237.16.32601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Leuven : University Hospital Leuven

Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease

Liège : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Liège : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Luxembourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Malmedy/Bellevaux-Ligneuville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mechelen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Menen : AZ Delta Updated

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Montigny-Le-Tilleul : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Oostende : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Oostende : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Roeselare : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turnhout : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Turnhout : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Verviers : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Wavre : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Zottegem : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Brazil

Belo Horizonte : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Florianopolis : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Goiania : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ribeirao Preto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rio de Janeiro : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Sao Paulo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

São Paulo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria

Dimitrovgrad : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Dupnitza : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gabrovo : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gabrovo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Haskova :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Kyustendil : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Montana : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novi Iskar :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pazardjik :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pleven :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pleven : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Pleven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Plovdiv : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Plovdiv : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Razgrad :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Ruse :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Ruse : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Ruse : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ruse : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sevlievo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Silistra : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sliven : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Sofia :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Sofia : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Troyan :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Troyan : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Varna :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Varna : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Varna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vidin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Vratsa :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Yambol : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Canada

Bridgewater : Forest Investigative Site 4041

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Burlington : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Burlington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Burlington : Forest Investigative Site 4055

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Calgary : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Calgary : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Calgary : University of Calgary

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Cornwall : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Downsview : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edmonton : Links Clinic

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : Grey Nuns Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : University of Alberta Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Gatineau : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Grimsby : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Halifax : Forest Investigative Site 3652

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hamilton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hamilton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Kelowna : Forest Investigative Site 3842

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kingston : Kingston General Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Kitchener : Forest Investigative Site 3830

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

La Malbaie : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Langley : Forest Investigative Site 3448

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lethbridge : Lethbridge Regional Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

London : Forest Investigative Site 3772

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

London : Forest Investigative Site 3754

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longueuil : Forest Investigative Site 3763

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mirabel : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mirabel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Moncton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Montreal Chest Institute

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Montreal : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Montreal : Montreal Chest Institute

Innovations in Treating COPD Exacerbations: Pilot Project on Action Plans Using New Technology

Montreal : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Forest Investigative Site 3495

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montreal : 1237.16.11601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

North Vancouver : Lion's Gate Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Ottawa : Ottawa Hospital General

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Penticton : Forest Investigative Site 3826

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pointe-Claire : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Quebec : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Quebec : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Quebec : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Québec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with Pulmonary Disease, Chronic Obstructive

Quebec City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Saint John's : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sainte-Foy : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Sarnia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Saskatoon : Royal University Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Saskatoon : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Saskatoon : Forest Investigative Site 3753

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Saskatoon : Royal University Hospita

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Saskatoon : 1237.16.11603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Sherbrooke : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sherbrooke : Forest Investigative Site 3764

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sherwood Park : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Sherwood Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

St Charles Borromee : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromee : Forest Investigative Site 4044

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St-Charles-Borromée : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St-Charles-Borromée : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St-Charles-Borromée : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Ste-Foy : 1237.16.11602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Sudbury : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sudbury : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sudbury : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sudbury : Forest Investigative Site 3829

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Thorold : Forest Investigative Site 4036

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toronto : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : Forest Investigative Site 4026

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toronto : Forest Investigative Site 3905

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toronto : Forest Investigative Site 2742

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Trois Rivieres : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Trois Rivieres : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Trois Rivières : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Truro : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Truro : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vancouver : St-Paul's Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Vancouver : St. Paul's Hospital

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease

Vancouver : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vancouver : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Vancouver : St. Paul' Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Vancouver : Vancouver General Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Waterloo : Forest Investigative Site 3887

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

West Vancouver : Forest Investigative Site 3827

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wetaskiwin : Wetaskiwin Lung Laboratory

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Windsor : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Windsor : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Windsor : Forest Investigative Site 2535

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winnipeg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Winnipeg : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Winnipeg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winnipeg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Winnipeg : Forest Investigative Site 3773

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chile

Puente Alto - Santiago : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Quillota : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Santiago : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Santiago : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Santiago : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Talca : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

China

Beijing : Novartis Investigative Site

A clinical research study for the treatment of COPD

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Changsha : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chengdu : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chengdu : 244.2514.86008 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Chongqing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chongqing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guang Zhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guang Zhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guangzhou : 244.2514.86007 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Guangzhou : 244.2514.86010 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Guangzhou : The First Affiliated Hospital of Guangzhou Medical College

Patients are needed to participate in a clinical research study evaluating Spiration Valve System and Medical Management for the treatment of Empyhsema

Guangzhou : Guangzhou Institute of Respiratory Diseases

Patients are needed to participate in a clinical research study of caspofungin to evaluate Invasive Pulmonary Aspergillosis or Chronic Obstructive Pulmonary Disease

Haikou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hangzhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hangzhou : 244.2514.86009 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Nanchang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nanjing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shanghai : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shanghai : 244.2514.86004 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Shengyang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shijiazhuang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Suzhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tianjin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tianjin : 244.2514.86002 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Xi'an : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Colombia

Armenia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bogota : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Floridablanca : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Medellín : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Croatia

Karlovac : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rijeka : University Hospital Rijeka

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Split : Clinical Hospital Center, Split

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Zagreb : Children's Hospital Srebrnjak

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Zagreb : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Zagreb : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Czech Republic

Benesov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Boskovice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Brno :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Cesky Krumlov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cvikov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jindrichuv Hradec : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Jindrichuv Hradec :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Jindrichuv Hradec : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Jindrichuv Hradec III : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Karlovy Vary : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Karlovy Vary : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Karlovy Vary :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Kralupy nad Vltavou : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Liberec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lovosice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Lovosice : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Melnik : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Melnik :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Olomouc : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Ostrava : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ostrava - Hrabuvka : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ostrava - Poruba : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Pardubice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Prague 4 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 10 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 10 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 4 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 4 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Praha 5 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 5 - Radotin :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Praha 6 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 6 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 6 - Repy : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 8 : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Praha 8 :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Rokycany : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Rokycany : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rudna : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Rudna u Prahy : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Strakonice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Strakonice : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Strakonice :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Teplice : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Teplice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Teplice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Teplice : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Teplice : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Trebic : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Varnsdorf : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Varnsdorf : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Zatec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Znojmo : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Denmark

Aalborg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Aalborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Aarhus C : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Århus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Arhus C : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Copenhagen NV : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hellerup : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hellerup : Dept. of Pulmonary Medicine Y, UH Gentofte

A clinical research study of Nightly NIV for at least 6 hours for the treatment of Chronic Obstructive Pulmonary Disease, Acute Exacerbation of Chronic Obstructive Airways Disease or Chronic Hypercapnic Respiratory Failure

Hellerup : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hvidovre : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hvidovre : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Hvidovre : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hvidovre : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Kobenhavn NV : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Kobenhavn NV : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

København NV : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

København NV : 1237.16.45002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Kolding : 1237.16.45003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Næstved : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Næstved : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Odense : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Odense : Department of Respiratory Medicine, Odense University Hospital

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Odense : 1237.16.45001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Odense C : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Odense C : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Odense C : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roskilde : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roskilde : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Silkeborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Silkeborg : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sønderborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Estonia

Paide : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallin : Institute of Clinical Medicine

Patients are needed to participate in a clinical research study of CHROMED monitoring system to evaluate Chronic Obstructive Pulmonary Disease, Congestive Hearth Failure or Sleep Disordered Breathing

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tartu : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tartu : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tartu : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tartu : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Finland

Helsinki : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Helsinki : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Helsinki : Biomedicum Helsinki

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

HUS : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jyvaskyla : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Kuopio : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pori : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turku : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Turku : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

France

Angers : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Angers cedex 9 : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Beuvry : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bletterans : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Briis Sous Forges : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Carbon Blanc : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Cournonterral : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dinard : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Donges : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Grandchamps : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Grenoble : CHU Updated

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Grenoble : CHU de Grenoble Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Grenoble cedex 9 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

La Bouexiere : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Fôret sur Sèvres : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Montagne : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Teste de Buch : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Le Bono : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Lille : Hôpital privé la Louvière

A clinical study for patients with COPD

Lille : CHU de Lille Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Lyon cedex 04 : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lyon cedex 04 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lyon cedex 04 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Marseille : CHU de Marseille Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Marseille : CHU Nord

Patients are needed to participate in a clinical research study of Simeox and Physiotherapy

Metz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montpellier cedex 5 : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Montpellier cedex 5 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Nantes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nantes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nantes cedex 2 : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nice : CHU Hôpital Pasteur Updated

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Nimes Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Paris : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Paris : Hôpital Bichat Updated

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Perigny : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Pessac : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pringy cedex : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Reims : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Reims : CHU de Reims Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Saint Etienne de Montluc : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Saint Georges de Montaigu : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Sarrebourg : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Seysses : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

St Genis des Fontaines : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Strasbourg : CHU de Strasbourg Updated

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Thouars : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Toulon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toulon : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Toulon : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tours : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Tours : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vannes : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Vieux Condé : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Villey Saint Etienne : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Vitré : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Witry les Reims : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Germany

Aachen :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Aachen : Boehringer Ingelheim Investigational Site 358

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Alfeld : Boehringer Ingelheim Investigational Site 259

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Ansbach : Boehringer Ingelheim Investigational Site 2

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Asbach-Bäumenheim : Boehringer Ingelheim Investigational Site 76

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Aschaffenburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Aschaffenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Auerbach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Auerbach : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Auerbach : Boehringer Ingelheim Investigational Site 169

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Auerbach : Boehringer Ingelheim Investigational Site 172

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Augsburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Augsburg : Boehringer Ingelheim Investigational Site 77

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Berka : Zentralklinik Bad Berka GmbH, Klinik für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Bad Berleburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Friedrichshall : Boehringer Ingelheim Investigational Site 38

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Krozingen : Boehringer Ingelheim Investigational Site 62

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Langensalza : Boehringer Ingelheim Investigational Site 161

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Lippspringe : Boehringer Ingelheim Investigational Site 323

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Neustadt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Reichenhall :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Bad Reichenhall : Boehringer Ingelheim Investigational Site 102

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Sachsa : Boehringer Ingelheim Investigational Site 262

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Windsheim : Boehringer Ingelheim Investigational Site 7

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Woerishofen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Woerishofen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bad Woerrishofen : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bad Wörishofen : Boehringer Ingelheim Investigational Site 74

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Baden-Baden : Boehringer Ingelheim Investigational Site 59

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bamberg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Bamberg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bamberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bamberg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Bamberg : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Beelitz-Heilstätten : Boehringer Ingelheim Investigational Site 217

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bensheim : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bensheim : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bensheim : Boehringer Ingelheim Investigational Site 144

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bergisch Gladbach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : HELIOS Klinikum Emil von Behring, Klinik für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Berlin : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Berlin : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Berlin : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : 1237.16.49603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QBM076 and placebo to evaluate COPD

Berlin : Boehringer Ingelheim Investigational Site 228

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 210

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 208

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 229

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 211

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 213

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 227

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 214

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 230

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 234

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 201

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 206

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 205

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 226

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bernkastel : Boehringer Ingelheim Investigational Site 103

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Biberach : Boehringer Ingelheim Investigational Site 71

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bielefeld : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bielefeld : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bielefeld : Boehringer Ingelheim Investigational Site 330

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bielefeld : Boehringer Ingelheim Investigational Site 331

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bochum : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bochum : 1237.16.49605 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Bochum : Boehringer Ingelheim Investigational Site 307

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bockenheim : Boehringer Ingelheim Investigational Site 130

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bodenwerder : Boehringer Ingelheim Investigational Site 260

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bonn : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bonn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bonn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bonn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bonn : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Bonn : Boehringer Ingelheim Investigational Site 360

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bonn : Boehringer Ingelheim Investigational Site 361

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bovenden : Evangelisches Krankenhaus Göttingen-Weende gGmbH, Abteilung für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Braunschweig : Boehringer Ingelheim Investigational Site 266

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 276

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 274

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 272

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Brinkum/Stuhr : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Bruchsal : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bruchsal : Boehringer Ingelheim Investigational Site 47

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bruchweiler-Bärenbach : Boehringer Ingelheim Investigational Site 128

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Buchbach : Boehringer Ingelheim Investigational Site 100

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bünde : Boehringer Ingelheim Investigational Site 325

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bünde : Boehringer Ingelheim Investigational Site 327

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Burgheim : Boehringer Ingelheim Investigational Site 78

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Calau : Boehringer Ingelheim Investigational Site 224

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Chemnitz : Boehringer Ingelheim Investigational Site 180

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Chemnitz : Boehringer Ingelheim Investigational Site 181

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cloppenburg : Boehringer Ingelheim Investigational Site 282

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cottbus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cottbus : Boehringer Ingelheim Investigational Site 233

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cottbus : Boehringer Ingelheim Investigational Site 232

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Deggendorf : Boehringer Ingelheim Investigational Site 91

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Delitzsch : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Delitzsch : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Delitzsch : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dessau : Boehringer Ingelheim Investigational Site 245

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dessau - Roßlau : Boehringer Ingelheim Investigational Site 241

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dessau-Rosslau : Boehringer Ingelheim Investigational Site 240

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dillingen : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Donaustauf :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Dortmund : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Dortmund : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Dortmund : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dortmund : Boehringer Ingelheim Investigational Site 311

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dortmund : Boehringer Ingelheim Investigational Site 309

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dortmund : Boehringer Ingelheim Investigational Site 310

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Drensteinfurt : Boehringer Ingelheim Investigational Site 318

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dresden : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : GSK Investigational Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dresden :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Dresden : Boehringer Ingelheim Investigational Site 184

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dudenhofen : Boehringer Ingelheim Investigational Site 137

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dueren : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Dueren : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Dueren : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Duisburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Duisburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Duisburg : Boehringer Ingelheim Investigational Site 291

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 286

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 297

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 293

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Düsseldorf : Boehringer Ingelheim Investigational Site 348

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eggenfelden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Eisenach : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Ellhofen : Boehringer Ingelheim Investigational Site 39

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Emmerich : Boehringer Ingelheim Investigational Site 290

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erfurt : Boehringer Ingelheim Investigational Site 162

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erlangen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Erlangen : Boehringer Ingelheim Investigational Site 6

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erlensee : Boehringer Ingelheim Investigational Site 151

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eschborn : Boehringer Ingelheim Investigational Site 146

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Essen : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Essen : Boehringer Ingelheim Investigational Site 300

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Boehringer Ingelheim Investigational Site 299

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Boehringer Ingelheim Investigational Site 298

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Euskirchen : Boehringer Ingelheim Investigational Site 359

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eutin : Boehringer Ingelheim Investigational Site 194

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eutin : Boehringer Ingelheim Investigational Site 195

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Falkensee : Boehringer Ingelheim Investigational Site 202

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Finsterwalde : Boehringer Ingelheim Investigational Site 231

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Floersheim : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Forchheim : Boehringer Ingelheim Investigational Site 9

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Framersheim : Boehringer Ingelheim Investigational Site 122

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Frankfurt : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Frankfurt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Frankfurt : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : 1237.16.49606 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QBM076 and placebo to evaluate COPD

Frankfurt : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : Boehringer Ingelheim Investigational Site 148

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : Boehringer Ingelheim Investigational Site 145

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt am Main : Boehringer Ingelheim Investigational Site 154

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freiberg : Boehringer Ingelheim Investigational Site 177

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freiburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Freising : Boehringer Ingelheim Investigational Site 80

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freital : Boehringer Ingelheim Investigational Site 182

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freital : Boehringer Ingelheim Investigational Site 179

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freudenberg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Freudenberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Friedrichshafen : Boehringer Ingelheim Investigational Site 69

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Friedrichsthal : Boehringer Ingelheim Investigational Site 106

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Friedrichsthal : Boehringer Ingelheim Investigational Site 107

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Fürstenwalde : Boehringer Ingelheim Investigational Site 236

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Fürstenwalde : Boehringer Ingelheim Investigational Site 235

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gailsdorf : Boehringer Ingelheim Investigational Site 1

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gangkofen : Boehringer Ingelheim Investigational Site 93

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Garmisch-Partenkirchen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Garmisch-Partenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Garmisch-Partenkirchen : Boehringer Ingelheim Investigational Site 88

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gauting :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Gauting : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gauting : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Geesthacht : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Geesthacht : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Geesthacht : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Geesthacht : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Gelsenkirchen : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Gelsenkirchen : Boehringer Ingelheim Investigational Site 301

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gelsenkirchen : Boehringer Ingelheim Investigational Site 303

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gelsenkirchen : Boehringer Ingelheim Investigational Site 302

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Geltow : Boehringer Ingelheim Investigational Site 223

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gera :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Germersheim : Boehringer Ingelheim Investigational Site 132

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Goch : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Goch : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Goch : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Göppingen : Boehringer Ingelheim Investigational Site 54

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Goslar : Boehringer Ingelheim Investigational Site 270

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Greifswald :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu